RAMBO, NCT01701934: Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease |
|
|
| Terminated | 2 | 14 | Canada | Roflumilast, DAXAS, Placebo, Inactive comparator | Laval University, Innovair, Takeda | Chronic Obstructive Pulmonary Disease, Metabolic Syndrome | 10/14 | 12/14 | | |